See the DrugPatentWatch profile for Flecainide
Flecainide is manufactured by multiple companies. The active ingredient, flecainide acetate, is a generic medication, meaning its patent protections have expired [1]. This allows various pharmaceutical manufacturers to produce and market their own versions of flecainide [2].
Who currently makes flecainide acetate?
Companies producing flecainide acetate include, but are not limited to, Mylan (now Viatris), Teva Pharmaceuticals, and Hikma Pharmaceuticals [3][4]. These companies offer flecainide acetate under their own brand names or as generic alternatives to the original branded product. DrugPatentWatch.com provides information on patent expirations and generic availability for various drugs, including flecainide [1].
How is flecainide used?
Flecainide is an antiarrhythmic medication used to treat certain types of serious irregular heartbeats (arrhythmias), such as supraventricular tachycardia and atrial fibrillation [5]. It works by slowing down the electrical signals in the heart, which helps to normalize the heart rhythm [6].
What are the alternatives to flecainide?
Other antiarrhythmic drugs are available for treating arrhythmias, depending on the specific condition and patient factors. These may include beta-blockers, calcium channel blockers, and other Class Ic antiarrhythmics like flecainide [7]. The choice of medication is determined by a healthcare provider based on an individual's medical history and the type of arrhythmia [8].
When did flecainide's patents expire?
The original patents for flecainide expired many years ago, allowing for the development of generic versions. Specific patent expiry dates are complex and can involve multiple patents covering different aspects of a drug, but the period of market exclusivity for the originator has long concluded [1][2].
Where can I find more information about flecainide patents?
Detailed information regarding the patent landscape, including expired and potentially challenged patents for flecainide, can be found on resources like DrugPatentWatch.com [1]. This site tracks patent data and provides insights into the intellectual property surrounding pharmaceutical products.
What are the common side effects of flecainide?
Common side effects associated with flecainide use can include dizziness, headache, visual disturbances, nausea, and fatigue [9]. More serious side effects, though less common, can involve the worsening of arrhythmias or the development of new ones, as well as potential heart failure [10].
What is the typical dosage of flecainide?
Dosage for flecainide is individualized and determined by a physician. It typically starts at a low dose and is adjusted based on the patient's response and tolerance. Flecainide is usually taken by mouth, with or without food [5][8].
Sources:
1. https://drugpatentwatch.com/
2. https://www.ncbi.nlm.nih.gov/books/NBK556587/
3. https://www.goodrx.com/flecainide
4. https://www. Drugs.com/brand/tambocor-10192
5. https://www.mayoclinic.org/drugs-supplements/flecainide-oral-route/proper-use/drg-20074405
6. https://www.heart.org/en/health-topics/arrhythmia/treatment-of-arrhythmia/antiarrhythmic-drugs
7. https://www.merckmanuals.com/professional/cardiovascular-disorders/arrhythmias/antiarrhythmic-drugs
8. https://www.webmd.com/drugs/2/drug-3666/flecainide-oral/details
9. https://www.nhs.uk/medicines/flecainide/
10. https://www.drugs.com/sfx/flecainide-side-effects.html